Veradigm | MDRX - Operating Profit


Veradigm reported $-45.47M in Operating Profit for its fiscal quarter ending in December of 2022.





Operating Profit Change Date
Alcidion AUD 2.2M 1.76M Dec/2025
Ambu A/S DKK 173M 9M Mar/2026
Amplifon EUR 48.08M 23.79M Dec/2025
Cardinal Health USD 861M 98M Mar/2026
Centene USD 1.86B 3.09B Mar/2026
Charles River Laboratories USD 119.9M 44.08M Mar/2026
Cigna USD 2.76B 204M Mar/2026
Coloplast 1.85B 102M Dec/2025
Computer Programs Systems USD -119.41M 121.35M Dec/2025
Convatec Group USD 175.7M 101.1M Dec/2024
CVS Health USD 4.68B 2.57B Mar/2026
Diasorin EUR 56M 8.57M Mar/2026
Elevance Health USD -5.81B 6.39B Mar/2026
General Electric Aerospace USD 2.32B 549M Mar/2026
Gulf Medical Proj AED 30.8M 8.97M Dec/2025
Humana USD 1.75B 2.56B Mar/2026
IQVIA Holdings USD 565M 2.11B Mar/2026
Laboratory Of America USD 410.1M 28.1M Mar/2026
Maximus USD 148.49M 2.28M Mar/2026
McKesson USD 1.84B 181M Mar/2026
Med Life RON 40.09M 1.45M Sep/2025
Molina Healthcare USD 176M 329M Mar/2026
Omnicell USD 17.04M 15.85M Mar/2026
Oriola-kd EUR 5.4M 1.2M Dec/2025
Owens Minor USD 814K 28.08M Dec/2025
Quest Diagnostics USD 399M 13M Mar/2026
Rede D'or Sao Luiz BRL 2.91B 350.85M Mar/2026
Siemens Healthineers EUR 726M 49M Mar/2026
Sonova Holding CHF 296.8M 156.9M Dec/2025
Supermax Corporation Bhd MYR -63.56M 79.6M Dec/2025
UnitedHealth USD 9.04B 5.78B Mar/2026
Veeva Systems USD 273.11M 27.24M Mar/2026
Veradigm USD -45.47M 70.47M Dec/2022
Xerox USD 30M 48M Jun/2025